We have studied the anti-tumor effects of human recombinant IL2, alone or in association with LAKcells, in mice transplanted subcutaneously (s.c.) with the following syngeneic tumors: highly metastatic Friend leukemia cells (FLC), nonmetastatic FLC, lymphoma RBL-5 cells and HeJ16 fibrosarcoma cells.
Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors
β Scribed by Avi Eisenthal; Yehuda Skornick; Ofer Merimsky; Ronit Hirsch; Vera Zakut; Ilan Ron; Samario Chaitchik
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 696 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Peripheral blood lymphocytes (PBL) and tumor-infiltrating lymphocytes (TIL) were isolated from six cancer patients and cultured in the presence of 100 units/ml of recombinant interleukin 2 (IL2). Both IL2-stimulated PBL (IL2-PBL) and IL2-stimulated TIL (IL2-TIL) lysed fresh and short-term cultured a
## Abstract The effect of lentinan on retardation and regression of transplanted tumors was analysed in allogeneic and syngeneic tumorβhost systems. The effect of lentinan treatment was most variable in randomβbred Swiss albino mice bearing sarcoma 180. With inbred host strains, it was most effecti